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Behavioral end points are being used with greater frequency in neurotoxicology to detect and
characterize the adverse effects of chemicals on the nervous system. Behavioral measures are
particularly important for neurotoxicity risk assessment since many known neurotoxicants do not
result in neuropathology. The chlorinated hydrocarbon class consists of a wide variety of chemicals
including polychlorinated biphenyls, clioquinol, trichloroethylene, hexachlorophene, organochlorine
insecticides (DDT, dicofol, chlordecone, dieldrin, and lindane), and phenoxyherbicides. Each of
these chemicals has effects on motor, sensory, or cognitive function that are detectable using
functional measures such as behavior. Furthermore, there is evidence that if exposure occurs
during critical periods of development, many of the chlorinated hydrocarbons are developmental
neurotoxicants. Developmental neurotoxicity is frequently expressed as alterations in motor
function or cognitive abilities or changes in the ontogeny of sensorimotor reflexes. Neurotoxicity
risk assessment should include assessments of the full range of possible neurotoxicological
effects, including both structural and functional indicators of neurotoxicity. Environ Health
Perspect 104(Suppl 2):353-360 (1996)
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Introduction
It has been estimated that there are
approximately 80,000 chemicals commer-
cially available and that 1,100 to 1,500
new chemicals are submitted annually for
premanufacture notification in the United
States alone (1). Many, but not all ofthese
chemicals undergo extensive toxicological
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evaluation before being approved for
the market.
During the last two decades, there
has been an increased interest in the ner-
vous system as a target organ for toxicity
(2-5). It is now well established that expo-
sure to some chemicals used in agriculture
and industry can produce neurotoxicity
characterized by motor, sensory, cognitive,
or autonomic nervous system dysfunction.
For example, obvious signs ofneurotoxicity
including muscle weakness, loss of motor
control and sensations in the periphery,
tremors, visual dysfunction, and cognitive
alterations have been reported by workers
exposed to some herbicides and insecticides.
In a review ofsigns and symptoms reported
by humans exposed to chemicals, Anger and
Johnson (6) identified more than 750
industrial chemicals as having neurotoxicity
following acute or repeated exposure. It
should also be noted that insidious prob-
lems of neurotoxicity may be undetected
because the effects are incorrectly attributed
to other conditions (e.g., advanced age,
mood disorders) orsimplymisdiagnosed.
Until recently, screening chemicals for
potential neurotoxicity depended heavily
on the identification of adverse effects on
the structure of the nervous system, i.e.,
neuropathology. Functional end points
including chemical-induced changes in
behavior, neurophysiology, and neuro-
chemistry are being used with increasing
frequency in the early phases of the risk
assessment process. Functional measures
are now viewed as a complement to the
usual neuropathological assessment. The
U.S. Environmental Protection Agency
(U.S. EPA), for example, recently pub-
lished a combined neurotoxicology screen-
ing protocol consisting of a functional
observational battery, motor activity, and
neuropathology (7).
Of the functional end points used in
neurotoxicology risk assessment, behavioral
measures are used with the most frequency.
The U.S. EPA, for example, has published
individual testing guidelines for a func-
tional observational battery, motor activity,
and schedule-controlled behavior, while
behavioral end points figure prominently in
guidelines to assess organophosphate-
induced delayed neuropathy (7). Neuro-
behavioral effects are important because
such changes are frequently associated with
human neurotoxic disorders. The National
Academy of Sciences (8) indicated that
behavior is the net result of integrated
sensory, motor, and cognitive function
occurring in the nervous system that and
chemical-induced changes in behavior may
be a relatively sensitive indicator ofnervous
system dysfunction. The brain is an
extremely complex organ, the function of
which is to receive and integrate signals and
then respond to them appropriately to
maintain bodily functions. Moreover, it
supports a diversity ofcomplex processes
including cognition, awareness, memory,
attention, vigilance, and language, all of
which are affected by exposure to chemicals
(6). The complexity ofthe interactions of
the nervous system with other organs pro-
vides a logical basis for the supposition that
changes in nervous system functioning may
occur on the dose-response curve of toxic
effects at doses lower than those required to
produce morphological or other changes.
Adverse behavioral effects were recog-
nized as the outcome of exposure to
chemicals by Weiss and Laties (5) over 20
years ago. Functional measures, especially
behavioral end points, are now used rou-
tinely to detect and characterize potential
neurotoxic effects ofchemicals (5,9,10). As
pointed out by Weiss (11,12), behavioral
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assessment is important because often one
of the earliest indications of exposure to
neurotoxicants is subtle behavioral impair-
ment such as paresthesia or short-term
memory dysfunction. Frequently, such
behavioral effects precede more obvious
and frank neurological signs.
The purpose of this paper is to under-
score the importance of functional
measures, particularly behavioral end
points, in neurotoxicity hazard evaluation.
To illustrate this point, the neurotoxico-
logical profile of the chlorinated hydrocar-
bon class of chemicals will be reviewed.
There is considerable structural diversity in
this class ofagents, and they are used for a
number of industrial and agricultural
purposes. Many ofthese compounds share
the ability to affect the nervous system; the
effects are usually reproducible in animals
and occur in most, if not all, subjects
exposed to appropriate doses. There are,
however, considerable qualitative differ-
ences in the symptomatologies and their
effects on the central nervous system (CNS).
They all have significant effects on the sen-
sory, motor, or cognitive functioning of
the nervous system.
Organopolychlorinated
Compounds
Polychlorinated biphenyls (PCBs) are a
group ofbiphenyl ring chemicals that con-
tain from one to nine chlorine atoms per
molecule, differing in the number and
position of atoms on the two rings. They
were formerly used in a wide range of
industrial products including hydraulic
fluids, plasticizers, adhesives, and dielectric
fluids in capacitors and transformers.
Commercial PCB mixtures are identified by
their percent chlorine content (on a weight
basis). Due to their chemical and thermal
stability they persist in environmental
media and accumulate in the food chain.
PCBs are classified as pollutants by the U.S.
EPA and are classified as 1 ofthe 100 most
significant hazardous substances by the
Centers for Disease Control (13,14).
Although PCBs were banned in the
United States in the 1970s, and subse-
quently elsewhere, residues persist in air,
soil, water, and sediment (15) and can be
detected in biologic tissue in most residents
of industrialized countries (16-18).
Because oftheir persistence, they continue
to be a health concern. Furthermore, they
continue to be used commercially in some
countries such as Argentina. Structurally
related compounds such as the polychlori-
nated dibenzofurans (PCDFs) and poly-
chlorodibenzo-p-dioxins (PCDDs) are
highly toxic even at low doses, accumulate
in a manner similar to PCBs, and frequently
occurwith PCBs in the environment.
Although there is little evidence to
suggest that PCBs are directly neurotoxic
in adults, there is considerable evidence
indicating that these chemicals are devel-
opmental neurotoxicants (19,20). Initial
evidence came from studies of pregnant
women in Japan and Taiwan who had
consumed cooking oil accidentally conta-
minated with large quantities of PCBs
and PCDFs. In addition to having
reduced birth size and dermatologic
anomalies, children born to these women
have shown poorer performance on stan-
dardized intelligence tests in follow-up
studies (20).
In addition, those with highest trans-
placental exposure to PCBs showed hypo-
tonia and hyporeflexia at birth and slowed
motor development through 2 years ofage,
a defect in visual memory processing at 7
months, and defects in short-term memory
at 4 years ofage (21,22). Prenatal exposure
(indicated by umbilical cord serum PCB
level) predicted poorer short-term memory
function on both verbal and quantitative
tests in a dose-dependent fashion. These
effects could not be attributed to a broad
range ofpotential confounding variables,
the impact of which was statistically
evaluated (22).
Quantities of PCBs much larger than
those received in utero are transferred to
the nursing infant postnatally through
breast-feeding because of the high lipid
content of milk (23). This high liposolu-
bility of organochlorides allows a high
mother's milk-plasma ratio, thereby repre-
senting a risk for nursing infants (24).
Although relatively small quantities of the
PCBs may reach the fetus, the literature
suggests the continuity of a toxic impact
received in utero and observed initially
during infancy. In general, these effects
may be related to alterations in cognitive
functioning fundamental to learning.
A review and a comparative evaluation
of PCB effects were recently published
(19,25). In general, developmental expo-
sure to PCBs results in persistent neurobe-
havioral alterations in monkeys and
nonprimates; similar neurobehavioral
effects are observed across species, and
such effects can occur in the absence of
reduced body weights or gross signs of
PCB intoxication. The most common
finding in animal studies was that develop-
mental exposure to PCBs results in behav-
ioral hyperactivity and alterations in higher
cognitive processes or learning. In humans,
developmental delays and impaired
cognitive function have also been reported.
The mechanism ofPCB-induced neuro-
toxicity is not fully understood. Seegal and
colleagues (26,27) have suggested that
some congeners, i.e., ortho-substituted
PCBs, may be neurotoxic. This observation
has been supported in a recent paper by
Kodavanti et al. (28). Other research (29)
indicates that PCB-induced hypothyrox-
inemia may be related to some aspects of
their developmental neurotoxicity.
Clioquinol
Clioquinol (5-chloro-7-iodo-8-hydroxy-
quinoline) was initiallyproduced as a topical
antiseptic and marketed as an oral intesti-
nal amebicide in 1934. Since then it has
been used for a wide number of intestinal
disorders including lambliasis, shigellosis,
balantidirial dysentery, chronic nonspecific
diarrheas, and "traveler's diarrhea" (30).
Thirty-five years ofworldwide acceptance
as an inexpensive, mass-produced remedy
for diarrhea with few recorded side effects
reinforced the notion that clioquinol was a
safe nonprescription drug.
However, in Japan between 1956 and
1972 (31,32), 10,000 cases of a subacute
myelo-optic neuropathy caused by clio-
quinol were reported. Experimental animal
studies were reported by Tateishi et al.
(33), Lannek and Jonsson (34), and
Heywood et al. (35), who reported that
subchronic administration ofclioquinol to
beagle dogs produces an abnormal gait at
one-third ofits LD50.
Chloroethylenes
Perchloroethylene (PERC) is a dry cleaning
solvent and metal degreasing agent.
Occupational exposure to PERC produces
spontaneous abortion or perinatal death
(36,37). With repeated exposure, prenar-
cotic effects, headaches, drowsiness, vertigo,
and fatigue have been reported in humans;
impairments of short-term memory and
psychomotor function have also been
reported (38).
Another chloroethylene is trichloroeth-
ylene (TCE), which is used as a dry clean-
ing agent, degreaser of metallic parts,
cleaning fluid, and paint remover. Visual
disturbances including peripheral visual-
field constriction, abnormal visual evoked
potential, and impairments in visuomotor
performance have been observed following
exposure to TCE. Longer term exposure
has been reported to result in impaired
visual performance (39). Case histories and
experimental exposures.in humans have not
revealed a specific set ofneurotoxicological
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effects following acute or repeated exposure
(40), but see Feldman andWhite (41).
Hexachlorophene
Hexachlorophene (HCPH) is an antibacte-
rial agent widely used in soap and antiseptic
solutions. Rats fed relatively large doses
have been found to suffer damage to white
matter and peripheral neuropathy (42).
Motor dysfunction has been observed in
adults exposed to HCPH (43,44). In addi-
tion, the synthesis ofmyelin was inhibited
in HCPH-treated rats (45). HCPH is read-
ily absorbed through the skin, and relatively
high blood levels of HCPH have been
found in children bathed in a 3% aqueous
solution, which was equivalent to two-
thirds ofthe amount causing a slight toxic
effect in rats (46). In France, the deaths of
more than 20 infants with neurological
manifestations ofencephalitis were attrib-
uted to the use ofa talcum powder contain-
ing an excess 6% HCPH (47). Goldey and
Taylor (48) have reported that rats exposed
to HCBH in utero were hyperactive upon
subsequent behavioral evaluation.
Organochlorinated Pesticides
Organochlorine pesticides are chlorinated
hydrocarbons that have been widely used in
agriculture and in the control ofdisease-
bearing insects. These chemicals vary
widely in structure and include hexachloro-
cyclohexanes or cycloparaffins (benzene
hexachloride [BHC] and lindane, the
gamma isomer ofhexachlorocyclohexane
[HCH]); chlorinated ethane derivatives or
halogenated aromatic compounds (dichloro-
diphenyltrichloroethane; DDT); cyclodi-
enes (dieldrin, aldrin, endrin, hepatachlor,
chlordane, chlordecone and mirex); and
toxaphene, which is a mixture of chlori-
nated terpenes (49). Although most of
these chemicals are insecticides, some are
also used as rodenticides (BHC), acaricides
(chlordimeform), fungicides (dichloro-
phen), or the herbicide chloroneb (1,4-
dichloro-2,5-dimethoxybenzene). Many of
them produce tremor or hyperresponsive-
ness to external stimulation (50-52). Other
problems include headaches, irritability,
insomnia, and a poorly described "neuroas-
thenic" or "asthenoautonomic" syndrome
characterized bydifficulty in thinking (53).
From the mid-1940s to the mid-1960s,
the organochlorine insecticides were used
widely in agriculture, soil and building
insect control, and malaria control
programs. As a class, however, they are
used less frequently because they tend to
persist in the environment and accumulate
in biologic as well as nonbiologic media.
They are, however, still important since
they can cause systemic poisoning and they
are still used in some countries (54).
In rats and mice, acute organochlorine-
pesticide poisoning produces tremor,
irregular muscle-jerking movements
(myoclonus), hyperexcitability, irritability,
hyperthermia, and clonic seizures, but the
characteristics of the abnormal motor
movements may differ with different
organochlorine pesticides (55). Appre-
hension and excitability followed by vari-
ous neurologic signs including twitching,
tremors, mental disorientation, weakness,
paresthesia, and convulsions, which are
often epileptiform, are the symptoms and
signs described in humans.
DDT
DDT is one of the best-known organo-
chlorine insecticides and produces a neuro-
toxic syndrome in both vertebrate and
invertebrate species. It is also a worldwide
environmental contaminant still used in
some countries (56). DDT is accumulated
in the food chain and known to be trans-
ferred from mother to offspring via milk
(57,58). In mice, DDT and some other
environmental pollutants, such as PCBs
and chlorinated paraffins, have been shown
to be retained to a greater extent in the
brain when given at 10 days of age than
when given at other ages (59,60). The lev-
els determined in human milk are more
than 10 times higher than those in cow's
milk (61). In many countries including
Argentina (62), Panama, Brazil (63,64),
Costa Rica (65), Guatemala and El
Salvador (66), Mexico (67), Nigeria (68),
and India (69,70), nursing infants poten-
tially ingest organohalogens at a ratio many
times that of the acceptable daily intake
(ADI) as estimated by the Food and
Agricultural Organization (71).
Neonatal exposure to a single low oral
dose of DDT can lead to a permanent
hyperactive condition in adult mice (72).
The consequence ofthe early exposure is
quite different from that reported for
animals exposed to a single dose of DDT
as adults. The signs ofpoisoning caused by
DDT in adults are characterized by several
behavioral manifestations including hyper-
activity, ataxia, tremors, and paralysis. The
principal neurophysiological mechanism of
action ofDDT is to slow the closing ofthe
voltage-dependent sodium channel once it
has been opened by the action potential,
with the result that the hyperexcitable
phase ofthe action potential is prolonged.
This is exhibited at the organismic level in
behavioral hyperexcitability (52,73).The
dose ofDDT required in adult animals to
provoke signs and effects such as ataxia,
tremor, increased activity in open-field
test, and avoidance responding is more
than 50 to 200 times the dose used for
neonatal exposure. This amount of DDT
is ofphysiological significance because it is
of the same order of magnitude that
humans can be exposed to during the
lactation period.
Dicofol
Dicofol [bis(chlorophenyl)2,2,2-trichloro-
ethanol] is an agricultural miticide for
crops such as cotton, beans, citrus, and
grapes. It is structurally related to DDT
and shares many ofits properties (74,75).
In humans, volunteer studies and case
reports have shown that exposure to high
doses of dicofol results in disturbance of
equilibrium, dizziness, confusion, head-
aches, tremors, fatigue, vomiting, twitch-
ing, seizures, and loss of consciousness
(74). Lessenger and Riley (76) reported
persistent cognitive and emotional difficul-
ties in a young male exposed to a relatively
high dose ofdicofol.
Chlordecone
The pesticide chlordecone (decachloro-
octahydro-1,3,4-metheno-2-H-cyclobutal
[cd]-pentalen-2-one), a cyclopentadiene
derivative, was manufactured in large
quantities in the United States before 1975
(77). Hazardous conditions at a manufac-
turing plant in Hopewell, Virginia, led to
epidemic poisoning ofworkers and conta-
mination ofthe James River in 1976. The
predominant signs ofpoisoningwere motor
incoordination, ataxia, tremors, opsoclonus
(uncontrolled eye movements), muscular
weakness, nervousness, pleuritic pain, joint
pain, hepatomegaly, abnormal liver func-
tion, skin rash, sterility, and weight loss
(78-80). As with other chlorinated hydro-
carbon insecticides, the CNS is one ofthe
major sites ofchlordecone's effects.
Chlordecone's neurotoxicity has also
been demonstrated in animal models.
Dietz and McMillan (81,82), for example,
compared the effects ofdaily administra-
tion of mirex and chlordecone on the per-
formance ofrats under several schedules of
reinforcement, including a multiple fixed-
interval 2-min fixed-ratio 12-response
schedule. Both pesticides produced delayed
disruption in performance, with the delay
being inversely proportional to the dose
administered daily. They reported that the
disruption often occurred before the
appearance ofgrossly observable signs of
exposure. Chlordecone also produces
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increased reactivity to external stimulation
and tremor in rats (50).
An interruption ofthe estrous cycle in
neonatal rats exposed to chlordecone was
observed (83). The reproductive toxicity
following exposure to chlorinated pesti-
cides such as chlordecone and DDT has
been attributed to their interaction with
the intracellular estradiol receptor. In the
female rodent, chlordecone disrupts both
the preovulatory LH surge and sexual
behavior. Chlordecone's toxicity includes
production of tremor and severe attenua-
tion ofreproductive function and decreased
sexual receptivity when treatment with the
pesticide occurs on the day ofproestrus in
intact females (84). Chlordecone's ability
to disrupt female reproductive behavior
may involve its disturbance of the sero-
tonin system, independent of its interac-
tion with the CNS estradiol receptor (85).
Tilson et al. (86) and Mactutus and Tilson
(87) reported persistent alterations in
learning and memory in rats exposed to
chlordecone postnatally.
Dieldrin
In many countries outside the United
States, dieldrin (a chlorinated cyclopentadi-
ene derivative) is used as a broad spectrum
insecticide to protect food crops and con-
trol disease vectors, locusts, and termites.
Unlike chlordecone, signs ofdieldrin poi-
soning in humans include severe tonic
seizures usually ofsudden onset, myoclonic
jerks, loss of appetite, mental disorder
including loss of memory and irritability,
and headache. In several cases, seizures
occurred many months after the last expo-
sure to dieldrin (88-90). Offspring from
mother rats fed dieldrin at levels often
found in the environment and with a low
protein diet showed altered behavioral
effects (91).
Burt (92) reported that dieldrin affected
the performance ofrats and Japanese quail
maintained under fixed-interval schedules
offood reinforcement. Dieldrin decreased
overall rates offixed-interval responding
and disrupted the within-interval pattern of
responding in both species. The effects of
dieldrin also persisted for at least 2 days
in rats and 5 days in quail following acute
administration.
Lindane
This organochlorine pesticide is used in
both human and veterinary medicine to
treat ectoparasites (93,94). In 1948,
Wooldridge (95) successfully treated
human scabies (skin disease caused by
mites) with 1% lindane cream, and this
treatment continues to be widely used. In
addition, lindane shampoo is used for
pediculosis (infestation with lice). While
dermal absorption is generally low, there
are exceptions. Lindane is also used as a
general insecticide, particularly in countries
outside the United States, to control struc-
tural pests such as termites although its
environmental persistence may not be
sufficient to make it satisfactory in this
capacity (94). There have been numerous
reports through the years of major toxic-
ity and death associated with accidental
or deliberate exposure to lindane (96).
Lindane is a potent convulsant agent in
humans and other mammals (96) as a
result ofa direct action on the CNS (97).
In the most severe incident (98), epidemic
poisoning occurred in India when lindane
intended for preservation ofseed grains was
instead mixed with food grains and was
consumed. The onset ofsigns ofpoisoning
was sudden with seizures ofthe mixed type,
i.e., grand mal, petit mal, and myoclonus,
predominating. Other effects included
intention tremors, memory impairment,
irritability, and aggression.
Desi (99) found that repeated exposure
to lindane increased the number of errors
made in a food-reinforced maze. One
interpretation of these results is that lin-
dane may interfere directly with learning.
Consistent with these data, it was reported
that lindane has effects on long-term
potentiation in the hippocampus, and it is
possible that this effect may compete or
interfere with the utilization of new infor-
mation. The post-training administration
oflindane did not affect retention. This
suggests that the process of memory con-
solidation is not altered (100). Data from
Tilson et al. (101) suggest that exposure to
nonconvulsant doses oflindane can inter-
fere with the ability to acquire and use new
information and that these effects may be
associated with alteration in GABA.
Although dieldrin and lindane have
quite different chemical structures, the
signs of poisoning that they produce are
similar in both insects and mammals.
Unlike the action ofDDT, which is on the
axonal membrane, the primary site of
action of lindane and dieldrin is the
synapse where both increase release ofneu-
rotransmitters (102). The action oflindane
was first studied in insects and shown to be
on the ganglia rather than on the axon. In
the cockroach, lindane and dieldrin were
both found to act on the cholinergic giant
fiber system in the abdominal ganglion and
to increase evoked and spontaneous release
ofacetylcholine (103,104). In addition, it
has been shown that lindane interacts with
the rat brain GABA receptor-ionophore
complex at the picrotoxinin binding site
(105); Matsumura and Ghiasuddin (106)
demonstrated that dieldrin and lindane
mimicked the action of picrotoxinin in
inhibiting GABA-stimulated chloride
uptake in cockroach muscle and competed
directly with picrotoxinin for binding in
rat brain synaptosomes.
Herbicides
The production and use of chemicals
for destruction of noxious weeds have
markedly increased worldwide during the
last 30 years and exceed insecticides in
quantity and value ofsales. Until recently,
it was widely believed that because plants
differ from animals in their morphology
and physiology, herbicides would be of
relatively low risk to animals and humans.
Recent experience with some herbicides,
however, has indicated that this assump-
tion is not valid. The chlorinated aromatic
acid compounds, 2,4-dichlorophenoxy
acetic acid (2,4-D) and 2,4,5-trichlorophe-
noxyacetic acid (2,4,5-T), have been widely
used as herbicides both in the United States
and in Vietnam as a component ofAgent
Orange. They have also been used as herbi-
cides in agriculture and forestry throughout
the world. It has been noted that the poly-
chlorinated dibenzo-p-dioxins (PCDDs),
particularly 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD), may contaminate some
phenoxyherbicide formulations.
Phenoxyherbicides are excreted in the
urine, and 2,4,5-T and 2,4-D have been
detected in the urine ofchildren living in an
area around a herbicide manufacturingplant
in Arkansas (107). 2,4-D appears in the
brain following in ovo or oral exposure
(108,109), and it has been suggested that
these agents might reach the brain by dam-
aging the blood-brain barrier (110,111).
Phenoxyherbicides are transported from the
cerebrospinal fluid via the organic anion
transport system, and inhibitors of this
transport may block its elimination from the
brain in vivo, just as they block its transport
by the isolated choroid plexus (112).
Desi and Sos (113) and Desi et al.
(114,115) observed, in acute and repeated
exposure experiments in rats, cats, and dogs
treated with 2,4-D, that cerebral electrical
activity was disturbed, including a gradual
slowing of the electroencephalogram.
Demyelination in the dorsal portion ofthe
spinal cord was observed in rats exposed to
relatively large doses of2,4-D. They con-
cluded that the site of action was either in
the cerebral cortex or in the reticular
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formation. These authors did not report
histological lesions in the CNS, although
Duffard et al. (116) described CNS hypo-
myelination in 1-day-old chicks born
from eggs externally treated with 2,4-D.
Evangelista de Duffard et al. (109) reported
that 2,4-D interfered with motor function
ofrats tested on a rotating rod; an increased
brain level of 5-HT and 5-HIAA in adult
rats exposed pre- and postnatally to 2,4-D
was also detected (117).
Humans exposed to 2,4-D have
reported neurologic symptoms that include
numbness in the fingers and toes, muscle
aches and fatigue, tetany ofthe limb mus-
cles, and ataxia (118). CNS effects have
also been reported and were manifested as
aberrant spontaneous electrical activity of
the cerebral cortex and reticular formation
as measured by EEG (119). Peripheral
neuropathies have also been ascribed to
2,4-D and 2,4,5-T. Singer et al. (120), for
example, described an increased prevalence
of slowed nerve conduction velocities
among chemical workers exposed to the
phenoxyherbicides 2,4,5-T and 2,4-D and
related contaminants (chlorinated dioxins).
The sural nerve seemed to be especially
affected. However, human exposure to
2,4-D has often been obscured by simulta-
neous exposure to other xenobiotics.
Alterations in motor function have also
been observed in rats exposed to repeated
doses of2,4-D (121).
Gender and the physiological state of
the animal appear to affect the manifesta-
tion of2,4-D-induced neurotoxicity. Our
laboratory demonstrated that oral adminis-
tration of 2,4-D butyl ester (2,4-Dbe) to
nulliparous females had no effect on either
open field (OF) or rotarod performance
(109). By contrast, dams treated with
2,4-Dbe during pregnancy exhibited
impairments of activity and rotarod.
Administration of2,4-Dbe to 90-day-old
intact male rats depressed spontaneous
activity and rotarod endurance. Castration
itself impaired performance in the rotarod
test but did not alter OF activity signifi-
cantly. The effects of castration were
reversed by exogenous testosterone. In
gonadectomized rats, 2,4-Dbe prevented
the reversal oftestosterone's effect on the
influence ofcastration on behavior ifgiven
concomitantly with testosterone.
However, when 2,4-Dbe treatment started
7 days after testosterone, the 2,4-Dbe
effects on OF and rotarod were reinstated.
Thus, the level of testosterone appears to
be important for causing the toxic effects
of2,4-Dbe in rats (109).
Table 1. Comparison of behavioral toxicity of
chlorinated hydrocarbons and related compounds.
Chemical orclass Neurobehavioral effects
Polychlorinated Developmental neurotoxicity,
biphenyls motoractivity, cognitive
function, developmental
delays
Clioquinol Motordysfunction
Trichloroethylene Visual neurotoxicant
Perchloroethylene Cognitive dysfunction,
vague symptoms of
neurotoxicity
Hexachlorophene Motor dysfunction,
developmental neurotoxicity
Organochlorine
pesticides
DDT Hyperexcitability, tremor in
adults, developmental
neurotoxicity
Dicofol Hyperexcitability, tremor
Chlordecone Hyperexcitability, tremor in
adults, developmental
neurotoxicity
Dieldrin Convulsant in adults,
developmental neurotoxicity
Lindane Convulsant in adults
Phenoxyherbicides
2,4-D Motordysfunction
Summary and Conclusions
The purpose ofthis paper is to illustrate the
importance ofbehavioral measurements in
assessing the neurotoxicity of chemical
agents. The chlorinated hydrocarbons sur-
veyed in this overview produce a wide spec-
trum of adverse effects on the nervous
system ofhumans and animals. Such effects
are summarized in Table 1 and include
motor dysfunction (clioquinol, hexa-
chlorophene, 2,4-D), visual impairment
(trichloroethylene), tremors and hyperex-
citability (DDT, dicofol, chlordecone),
seizurigenic activity (dieldrin, lindane), and
cognitive alterations (perchloroethylene).
Several ofthe compounds are also develop-
mental neurotoxicants (PCBs, hexachloro-
phene, DDT, chlordecone, and dieldrin).
Chemical-induced neuropathology, how-
ever, is associated with only a few ofthese
neurotoxicants including clioquinol,
trichloroethylene, hexachlorophene, and
2,4-D. Chemical-induced changes in
motor, sensory, or cognitive function are
clearly cardinal indicators ofexposure to the
chlorinated hydrocarbons.
Unlike pharmacological agents and
natural or synthetic toxins, many industrial
and pesticidal agents are not designed to
affect a specific biological function or inter-
act with aspecific receptor site at the cellular
or molecular level. It is expected that many
chemicals will have multiple mechanisms of
toxic effect. Because many behavioral
measures are apical tests, they may be better
suited to assess chemicals with unknown or
multiple mechanisms during the initial
stages ofhazard evaluation.
One ofthe main tasks oftoxicology and
risk assessment is to determine, through
experiments with animals and documenta-
tion ofadverse effects following accidental
exposure ofhumans, safe limits ofexposure
to toxic chemicals. Since new chemicals are
being released into the environment at a
relatively steady pace, it is essential to use
rapid and sensitive toxicological screening
procedures for these and already existing
chemicals. The survey ofthe literature pre-
sented in this paper supports the strategy of
including behavioral tests of sensory,
motor, and cognitive function in the initial
phases of hazard identification. Once
behavioral neurotoxic effects have been
identified, it is important to improve the
understanding ofthe mechanisms of neu-
rotoxicity at the neurochemical, neuro-
physiological, cellular, and molecular levels
ofanalysis. Neurotoxicity risk assessment
will be improved by a more complete
understanding of the interrelationships
between the various levels of nervous sys-
tem organization. Knowledge about the
capability ofhumans and other organisms
to cope behaviorally with conditions of
their physical environment can add impor-
tant information useful to decision makers
and legislators concerned with environmen-
tal toxicology. Neurobehavioral toxicology
contributes directly to this issue by system-
atically assessing the threshold and magni-
tude of exposure beyond which normal
processes ofnervous system functioning are
significantly affected.
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